2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$439.53+$0.19 (+0.04%)
Price as of Aug 21, 2026 7:56 PM EDT- $234.6BMarket Cap
- 53.72%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$439.53+$0.19 (+0.04%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $439.33 | ||
Change | +$8.12 (+1.88%) | ||
Open | $431.72 | ||
High | $440.51 | ||
Low | $429.38 | ||
Previous Close | $433.73 | ||
Volume | 2,114,752 | ||
30-Day Average Volume | 2,713,932 | ||
1-Week Change | 6.43% | ||
1-Month Change | 20.66% | ||
1-Year Change | 53.72% | ||
3-Year Change | 84.37% | ||
5-Year Change | 129.63% | ||
Fundamentals | |||
Shares Outstanding | 541.0M | ||
Total Assets | $95.6B | ||
Market Cap | $234.6B | ||
Enterprise Value | $278.0B | ||
Period: QTR TTM FY | |||
Revenue | $9.5B | ||
Net Income | $2.4B | ||
Free Cash Flow | $3.5B | ||
EBIT | $3.4B | ||
EBITDA | $4.6B | ||
Net Working Capital | $9.5B | ||
EPS | $4.37 | ||
Enterprise Value/EBITDA | 61 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 20 | ||
P/E | 101 | ||
PEG | 3 | ||
Price/Free Cash Flow | 68 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.29% | ||
Trailing Annual Dividend Yield | 2.80% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield